Olmefit H 12.5 mg/40 mg Tablet
By Olmefit H
Rx
10 Tablet in a Strip

Composition
Hydrochlorothiazide(12.5mg) + Olmesartan Medoxomil(40mg)

Manufacturer - Fidelity Lifesciences Pvt Ltd
3rd Floor, Suvidha House, Plot No. 2, Shipra Society, Vithal Mandir Road, Above Andhra Bank, Karvenagar, Pune 411052

Expires on or after
October, 2025

liver
**Olmefit H 12.5 mg/40 mg Tablet should be taken cautiously by individuals with liver disease. It may be necessary to adjust the dosage of Olmefit H 12.5 mg/40 mg Tablet for these patients. It is important to consult your doctor before using this medication if you have any liver issues.

kidney
"Olmefit H 12.5 mg/40 mg Tablet requires caution in severe kidney disease. Dosage adjustment may be necessary. Consult your doctor for proper guidance. Monitor blood pressure regularly for adjustments."

alcohol
Olmefit H 12.5 mg/40 mg Tablet can lead to extreme drowsiness when combined with alcohol.

driving
When taking Olmefit H 12.5 mg/40 mg Tablet, be cautious while driving as it may cause reduced alertness, impact vision, or induce drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Olmefit H 12.5 mg/40 mg Tablet is not safe to use during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Olmefit H 12.5 mg/40 mg Tablet is considered safe for use during breastfeeding. Human data indicates minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹120
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024